Inclusion Criteria : 
  1.  All the cases with the primary diagnosis of acute or chronic synthetic cannabinoids toxicity will be included in the study . 
  2.  Willing and able to comply with the study procedures and provide written informed consent to participate in the study . 
Exclusion Criteria : 
  -  1 - Patients with a history of any chronic disease ( renal and hepatic ) .  2 - Patients refuse to participate in the study.  3 - Abuse to other drugs.